Clinical trial
Proof-of-concept Study of Efficacy and Safety of Dietary Supplementation With Probiotics in IgAN Patients
NCT01781312 is registered in ClinicalTrials.gov with Uppsala University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Proof-of-concept Study of Efficacy and Safety of Dietary Supplementation With Probiotics in IgAN Patients
- Lead sponsor
- Uppsala University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2013
- Completion date
- August 31, 2014
- Enrollment
- 20 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
iga nephropathy